FDA Clears Vivos Therapeutics' Oral Device for Sleep Apnea

Vivos Therapeutics said on Wednesday the US health regulator has cleared its oral device for severe obstructive sleep apnea, leading a massive rally in the company's shares before the bell.
Reuters Health Information

source https://www.medscape.com/s/viewarticle/998876?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension